Role of genetic and expression profiling in pharmacogenomics: The changing face of patient management

Current Issues in Molecular Biology

Volumn 4, Issue 4, 2002, Pages 101-110

  Pagliarulo, Vincenzo ^a   Datar, Ram H ^a   Cote, Richard J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CODEINE; CYTOCHROME P450 2D6; DEBRISOQUINE; FLUOROURACIL; GEMCITABINE; IRINOTECAN; ISONIAZID; MERCAPTOPURINE; METHOTREXATE; MONOCLONAL ANTIBODY; MORPHINE; NORTRIPTYLINE; ONYX 015; RECOMBINANT PROTEIN; TAMOXIFEN; THIOPURINE METHYLTRANSFERASE; TIOGUANINE; TRASTUZUMAB; WARFARIN; ANTINEOPLASTIC ANTIMETABOLITE;

ARTICLE; BIOMEDICINE; BREAST CANCER; CHILDHOOD LEUKEMIA; COLORECTAL CANCER; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRUG RESPONSE; DRUG SAFETY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SEQUENCE; GENE TECHNOLOGY; GENETIC VARIABILITY; HEMATOLOGIC DISEASE; HUMAN; INDIVIDUALIZATION; MEDICAL PRACTICE; MEDICAL RESEARCH; MOLECULAR GENETICS; ORTHOSTATIC HYPOTENSION; PATIENT CARE; PATIENT RIGHT; PHARMACOGENOMICS; PREDICTION; PROFESSIONAL SECRECY; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TREATMENT PLANNING; DRUG DESIGN; GENOME; METABOLISM; MOLECULAR BIOLOGY; PHARMACOGENETICS; REVIEW;

ANTIMETABOLITES, ANTINEOPLASTIC; DRUG DESIGN; FLUOROURACIL; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MOLECULAR BIOLOGY; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0036808725     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Editorial. 1997. The cost of adverse drug reactions. Adverse Drug React. Toxicol. Rev. 16: 75-78.
2. Apostolakos, M.J. Schuermann, W.H.T. Frampton, M.W. Utell, M.J., and Willey, J.C. 1994. Measurement of gene expression by multiplex competitive polymerase chain reaction. Anal. Biochem. 213: 277-284.
3. Arenkov, P. Kukhtin, A. Gemmell, A. Voloshchuk, S. Chupeeva, V., and Mirzabekov A. 2000. Protein microchips: Use for immunoassay and enzymatic reactions. Anal. Biochem. 278: 123-131.
4. Banks, R.E. Dunn, MJ. Forbes, M.A. Stanley, A. Pappin, D. Naven, T. Gough, M. Harnden, P., and Selby P.J. 2000. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis. Electrophoresis. 20: 689-700.
5. Barrett, A. 2000. The pharma frenzy: in the race for gene-based therapies, big drug-makers join forces with upstarts. Business Week June: 160-161.
6. Bertilsson, L. Dahl, M.L. Sjoqvist, F. Aberg.Wistedt, A. Humble, M. Johansson, I. Lundqvist, E., and Ingelman-Sundberg, M. 1993. Molecular basis for rational mega-prescribing in ultra-rapid hydroxylators of debrisoquin. Lancet. 341: 363.
7. Bischoff, J. R. Kirn, D. H. Williams, A. Heise, C. Horn, S. Muna, M. Ng, L. Nye, J. A. Sampson-Johannes, A. Fattaey, A., and McCormick, F. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumour cells. Science. 274: 373-376.
8. Bowater, R.P., and Wells, R.D. 2001. The intrinsically unstable life of DNA triplet repeats associated with human hereditary disorders. Prog. Nucleic Acid Res. Mol. Biol. 66: 159-202.
9. Boyle, M.D. Romer, T.G. Meeker, A. K., and Sledjeski, D. D. 2001. Use of surface-enhanced laser desorption ionization protein chip system to analyze streptococcal exotoxin B activity secreted by Streptococcus pyogenes. J. Microbiol. Methods. 46:87-97.
10. Broly, F. Gaedigk, A. Heim, M. Eichelbaum, M. Morike, K., and Meyer, U.A. 1991. Debrisoquine/sparteine hydroxylation genotype and phenotype: Analysis of common mutations and alleles of CYP2D6 in European population. DNA Cell. Biol. 10: 545-558.
11. Brown, P.O., and Botstein, D. 1999. Exploring the new world of the genome with DNA microarrays. Nature Genet. 21: 33-7.
12. Capaldi, S. Getts, R.C., and Jayasena, S.D. 2000. Signal amplification through nucleotide extension and excision on a dendritic DNA platform. Nucleic Acids Res. 28: E21.
13. Carson, R.T., and Vignali, D.A. 1999. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods. 227: 41-52.
14. Cathomen, T., and Weitzman, MD. 2000. A functional complex of adeno-virus proteins E1B-55kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity. J. Virol. 74: 11407-11412.
15. Chiem, N.H., and Harrison, D.J. 1998. Microchip systems for immunoassay: an integrated immunoreactor with electrophoretic separation for serum theophylline determination. Clin. Chem. 44: 591-598.
16. Claverie, J.M. 2001. What if there are only 30,000 human genes? Science. 291: 1255-7.
17. Colomer, R. Shamon, L.A. Tsai, M.S., and Lupu, R. 2001. Herceptin: from the bench to the clinic. Cancer Invest. 19: 49-56.
18. Dahl, M.L., and Sjoqvist, F. 2000. Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics. Ther. Drug. Monit. 22: 114-117.
19. Dahl, M.L. Johansson, I. Porsmyr Palmertz, M. Ingelman-Sundberg, M., and Sjoqvist, F. 1992. Analysis of the CYP2D6 gene in relation to debrisoquine and desipramine hydroxylation in a Swedish population. Clin. Pharmacol. Ther. 51: 12-17.
20. Davies, H.A. 2000. The protein chip system from Ciphergen: a new technique for rapid, micro-scale protein biology. J. Mol. Med. 78: B29.
21. Drummond, J.T 1999. Genomic amplification of the human DHFR/MSH3 locus remodels mismatch recognition and repair activities. Adv. Enz. Regul. 39: 129-41.
22. Duggan, B.J. Maxwell, P. Kelly, J.D. Canning, P., anderson, N.H. Keane, P.F. Johnston, S.R., and Williamson, K.E. 2001. The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma. J. Urol. 166: 1098-105.
23. Ekins, R., and Chu, F.W. 1991. Multianalyte microspot immunoassay-microanalytical 'compact disk'of the future. Clin. Chem. 37:1955-1967.
24. Ekins, R., and Chu, R.W. 1997. In: Principals and Practices of Immunoassays 2nd Edn, Eds Price, C. P., and Newman, D. J. Stockton, New York.p. 625-646.
25. Ekins, R., and Chu, F.W. 1999. Microarrays: their origins and applications. Trends. Biotechnol. 17: 217-218.
26. Emmert-Buck, M.R. Gillespie, J.W. Paweletz, C.P. Ornstein, D.K. Basrur, V. Appella, E. Wang, Q.H. Huang, J. Hu, N. Taylor, P., and Petricoin, E.F. 3rd. 2000. An approach to the proteomic analysis of human tumors. Mol. Carcinogen. 27: 158-165.
27. Evans, D.A.P. Manley, K.A., and McKusick, V.A. 1960. Genetic control of isoniazid metabolism in man. Br. Med. J.2:485-491.
28. Evans, W.E., and Relling, M.V. 1999. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 286: 487-491.
29. Flanagan, A. 2000. Screening technologies evolve: innovations spurred by race to profit from genetic data. Genet. Eng. News. 20: 19-20.
30. Fulton, R.J. McDade, R.L. Smith, P.L. Kienker, L.J., and Kettman, J.R. Jr. 1997. Advanced multiplexed analysis with the FlowMetrix system. Clin. Chem. 43:1749-1756.
31. Gorlick, R. Metzger, R. Danenberg, K.D. Salonga, D. Miles, J.S. Longo, G.S. Fu, J. Banerjee, D. Klimstra, D. Jhanwar, S. Danenberg, P.V. Kemeny, N., and Bertino, J.R. 1998. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J.Clin.Oncol. 16: 1465-1469.
32. Grant, D.M., and Phillips, M.S. 2001. Technologies for the analysis of single-nucleotide polymorphisms: an overview. In: Pharmacogenomics. Eds. Kalow, Meyer and Tyndale. Published by Marcel Dekker, Inc. New York, volume 113, pages 183-190.
33. Green, C.D. Fredrik, J.S. Taillon, B.E. and Lewin, D.A. 2001. Open Systems: Panoramic Views of Gene Expression. J. Immunol. Methods. 250: 67-79.
34. Gygi, S.P. Rist, B. Gerber, S.A. Turecek, F. Gelb, M.H., and Aebersold, R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnol. 17: 994-999.
35. Hacia, J.G. Brody, L.C. Chee, M.S. Fodor, S.P., and Collins, F.S. 1996. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nature Genet. 14: 441-7.
36. Hancock, W. Apffel, A. Chakel, J. Hahnenberger, K. Choudhary, G. Traina, J.A., and Pungor, E. 1999. Integrated genomic/proteomic analysis. Anal. Chem. 71, 743-748.
37. Heim, M.H., and Meyer, U.A. 1990. Genotyping of poor metabolizers of debrisoquine by allele specific PCR amplification. Lancet. 336: 529-532.
38. Humphery-Smith, I. Cordwell, S.J., and Blackstock, W.P. 1997. Proteome research: Complementarity and limitations with respect to the RNA and DNA worlds. Electrophoresis. 18: 1217-1242.
39. Iqbal, S., and Lenz, H.J. 2001. Determinants of prognosis and response to therapy in colorectal cancer. Curr. Oncol. Reports. 3: 102-108
40. Iyer, L. King, C.D. Whitington, P.F. Roy, S.K. Green, M.D. Tephly, TR. Coffman, B.L., and Ratain, M.J. 1998. Genetic predisposition to the metabolism of irinotecan: role of UGT1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J. Clin. Invest. 101: 847-854.
41. Johnston, P. Lenz, H.J. Leichman, C.G. Danenberg, K.D. Allegra, C.J. Danenberg, P.V., and Leichman, L. 1995. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer. Res. 55: 1407-1412.
42. Jones, V.W. Kenseth, J.R. Porter, M.D. Mosher, C.L., and Henderson, E. 1998. Microminiaturized immunoassays using atomic force microscopy and compositionally patterned antigen arrays. Anal. Chem. 70: 1233-1241.
43. Kallioniemi, O.P. Wagner, U. Kononen, J., and Sauter, G. 2001. Tissue microarray technology for high-throughput molecular profiling of cancer. Human Molecular Genetics. 10: 657-62.
44. Lazarou, J. Pomeranz, B.H., and Corey, P.N. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J. A. M. A. 279: 1200-1205.
45. Leichman, C.G. Lenz, H.J. Danenberg, K.D. Leichman, L. Danenberg, K.D. Baranda, J. Groshen, S. Boswell, W. Metzger, R. Tan, M., and Danenberg, P.V. 1997. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted infusion fluorouracil and weekly leucovorin. J. Clin. Oncol. 15: 3223-3229.
46. Lenz, H.J. Hill, C. Danenberg, K.D. Leichman, L.L. Priest, D.G., and Danenberg, P.V. 1995. Rapid quantitative PCR for determination of relative gene expressions in tissue specimens. PCR Meth. Appl. 4: 305-309.
47. Liang, P., and Pardee, A.B. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257: 967-971.
48. Lockhart, D.J. Dong, H. Byrne, M.C. Follettie, M.T. Gallo, M.V. Chee, M.S. Mittmann, M. Wang, C. Kobayashi, M. Horton, and H. Brown, E.L. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotech. 14: 1675-80.
49. Lueking, A. Horn, M. Eickhoff, H. Bussow, K. Lehrach, H., and Walter, G. 1999. Protein microarrays for gene expression and antibody screening. Anal. Biochem. 270: 103-111.
50. Luo, L. Salunga, R.C. Guo, H. Bittner, A. Joy, K.C. Galindo, J.E. Xiao, H. Rogers, K.E. Wan, J.S. Jackson, M.R., and Erlander, M.G. 1999. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nature Med. 5, 117-122.
51. MacBeath, G., and Schreiber, S. L. 2000 Printing Proteins as Microarrays for High-Throughput Function Determination. Science. 289: 1760-1763.
52. Mahgoub, A. Idle, J.R. Dring, L.G. Lancaster, R., and Smith, R.L. 1977. Polymorphic hydroxylation of debrisoquine in man. Lancet. 2: 584-586.
53. Mendoza, L.G. McQuary, P. Mongan, A. Gangadharan, R. Brignac, S., and Eggers, M. 1999. High throughput microarray based enzyme linked immunosorbant assay. BioTechniques. 27: 778-788.
54. Meyer, U.A. 2000. Pharmacogenetics and adverse drug reactions. Lancet 356, 1667-1671.
55. Murakami, T Hagiwara, T. Yamamoto, K. Hattori, J. Kasami, M. Utsumi, M., and Kaneda, T. 2001. A novel method for detecting HIV-1 by non-radioactive in situ hybridization: application of a peptide nucleic acid probe and catalysed signal amplification. J. Pathol. 194: 130-5.
56. Narang, U. Gauger, P.R. Kusterbeck, A.W., and Ligler, F.S. 1998. Multianalyte detection using a capillary-based flow immunosensor. Anal. Biochem. 255: 13-19.
57. Noah, B.A. 2000. Adverse drug reactions: harnessing experiential data to promote patient welfare. Catholic U. Law Rev. 49: 449-504.
58. Page, M.J. Amess, B. Townsend, R.R. Parekh, R. Herath, A. Brusten, L. Zvelebil, M.J. Stein, R.C. Waterfield, M.D. Davies, S.C., and O'Hare, M.J. 1999. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc. Natl. Acad. Sci. USA. 96: 12589-12594.
59. Paweletz, C.P. 2000. (SELDI) Biomarker profiling of stages of cancer progression directly from human tissue using a protein biochip. Drug Develop. Res. 49: 34-42.
60. Pease, A.C. Solas, D. Sullivan, E.J. Cronin, M.T. Holmes, C.P., and Fodor, S.P. 1994. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc. Natl. Acad. Sci. USA. 91: 5022-6.
61. Pegram, M.D. Konecny, G., and Slamon, D.J. 2000. The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer. Cancer Treatment and Research. 103: 57-75.
62. Peltomaki, P. 2001. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum. Mol. Genet. 10: 735-40.
63. Piccart, M. Lohrisch, C. Di Leo, A., and Larsimont, D. 2001. The predictive value of HER2 in breast cancer. Oncology. 61: 73-82.
64. Rich, R.L. Day, Y.S. Morton, T.A., and Myszka, D.G. 2001. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. Anal Biochem. 296:197-207.
65. Rolfs, A. Schuller, I. Finckh, U., and Weber-Rolfs, I. 1992. PCR: Clinical diagnostics and research. Springer-Verlag, Berlin. p. 1-271.
66. Rooney, P.H. Stevenson, D.A. Marsh, S. Johnston, P.G. Haites, N.E. Cassidy, J., and McLeod, H.L. 1998. Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors. Cancer Res. 58: 5042-5045.
67. Rothstein, M.A. 1998 Genetic privacy and confidentiality: why they are so hard to protect. J. Law Med. Ethics 26: 198-204.
68. Rowe, C.A. Tender, L.M. Feldstein, M.J. Golden, J.P. Scruggs, S.B. MacCraith, B.D. Cras, J.J., and Ligler, F.S. 1999. Array biosensor for simultaneous identification of bacterial, viral, and protein analytes. Anal. Chem. 71: 3846-3852.
69. Salonga, D. Danenberg, K.D. Johnson, M. Metzger, R. Groshen, S. Tsao-Wei, D.D. Lenz, H.L. Leichman, C.G. Leichman, L. Diasio, R.B., and Danenberg, P.V. 2000. Gene expression levels of dihydropyrimidine dehydrogenase and thymidylate synthase together identify a high percentage of colorectal tumors responding to 5-fluorouracil. Clin. Cancer Res. 6: 1322-1327.
70. Shriver-Lake, L.C. Ogert, R.A., and Ligler, F.S. 1993. A fiber optic evanescent-wave immunosensor for large molecules. Sensors Actuators. 11: 239-243.
71. Silzel, J.W. Cercek, B. Dodson, C. Tsay, T., and Obremski, R.J. 1998. Mass-sensing multianalyte microarray immunoassay with imaging detection. Clin. Chem. 44: 2036-2043.
72. Southern, E.M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98: 503-17.
73. Southern, E.M. Case-Green, S.C. Elder, J.K. Johnson, M. Mir, K.U. Wang, L., and Williams, J.C. 1994. Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids. Nucleic Acids Res 22: 1368-73.
74. The international human genome mapping consortium. 2001. A physical map of the human genome. Nature. 409, 934-941.
75. Tsujitani, S. Konishi, I. Suzuki, K. Oka, S. Gomyo, Y. Matsumoto, S. Hirooka, Y., and Kaibara, N. 2000. Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients. J. Exp. Clin. Canc. Res. 19: 189-95.
76. Van Triest, B. Pinedo, H.M. Giaccone, G., and Peters, G.J. 2000. Downstream molecular determinants of response to 5 fluorouracil and antifolate thymidylate synthase inhibition. Annals Oncol. 11:385-391.
77. Vasiliskov, A.V. Timofeev, E.N. Surzhikov, S.A. Drobyshev, A.L. Shick, V.V, and Mirzabekov, A.D. 1999. Fabrication of microarray of gel-immobilized compounds on a chip by copolymerization. Bio Techniques. 27: 592-606.
78. Volkenandt, M. Dicker, A.P. Banerjee, D. Fanin, R. Schweitzer, B. Horikoshi, T. Danenberg, K. Danenberg, P., and Bertino, J.R. 1992. Quantitation of gene copy number and mRNA using the polymerase chain reaction. Proc. Soc. Exp. Biol. Med. 200: 1-6.
79. Wadkins, R.M. 1998. Biosensors and bioelectronics: detection of multiple toxic agents using a planar array. Immunosensor. 13: 407-415.
80. Weinshilboum, R. 2001. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyl transferase. Drug Metabolism and Dispos. 29: 601-605.
81. Willey, J.C. Crawford, E.L. Jackson, C.M. Weaver, D.A. Hoban, J.C. Khuder, S.A., and DeMuth, J.P. 1998. Expression Measurement of Many Genes Simultaneously by Quantitative RT-PCR Using Standardized Mixtures of Competitive Templates. Am. J. Respir. Cell. Mol. Biol. 19: 6-17.
82. Wolf, C.R. Smith, G., and Smith, R.L. 2000. Science, medicine and the future: pharmacogenetics. Brit. Med. J. 320: 987-990.
83. Wu, G., Datar, R.H., Hansen, K.M., Thundat, T, Cote, R.J., and Majumdar, A. 2001. Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nature Biotechnol. 19: 856-860.